PRESTRELSKI STEVEN

CIK 00017440272 companiesCHICAGO, IL

SEC Profile

Transactions

Companies

Filings

CIK

0001744027

Recent Transactions

44 trades

Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2023-01-31+150,000→ 719,780 total
Sale
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2022-02-22$2.42/sh−11,228→ 569,780 total
Exercise/Conversion
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2022-02-22$0.69/sh+11,228→ 581,008 total
Exercise/Conversion
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2022-02-22−11,228→ 0 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2022-01-03+75,000→ 569,780 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2021-10-05+110,000→ 494,780 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Common Stock
2021-10-05−384,780→ 110,000 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Common Stock
2021-10-05−110,000→ 0 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−11,266→ 0 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−25,000→ 0 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−14,036→ 0 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−25,000→ 0 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−11,228→ 0 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−28,072→ 0 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+25,000→ 25,000 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2021-10-05+384,780→ 384,780 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+14,036→ 14,036 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+25,000→ 25,000 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+11,266→ 11,266 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+28,072→ 28,072 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+11,228→ 11,228 total
Sale
XERIS PHARMACEUTICALS INC
Common Stock
2021-04-12$4.07/sh−10,000→ 496,824 total
Award
XERIS PHARMACEUTICALS INC
Common Stock
2021-01-29+100,000→ 506,824 total
Sale
XERIS PHARMACEUTICALS INC
Common Stock
2021-01-13$6.01/sh−10,000→ 406,824 total
Sale
XERIS PHARMACEUTICALS INC
Common Stock
2021-01-11$5.72/sh−10,000→ 416,824 total
Gift
XERIS PHARMACEUTICALS INC
Common Stock
2020-12-16−10,000→ 426,824 total
Award
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2020-08-14+25,000→ 25,000 total
Award
XERIS PHARMACEUTICALS INC
Common Stock
2020-01-31+15,000→ 436,824 total
Sale
XERIS PHARMACEUTICALS INC
Common Stock
2020-01-13$5.50/sh−10,000→ 421,824 total
Gift
XERIS PHARMACEUTICALS INC
Common Stock
2019-11-19−17,500→ 431,824 total
Sale
XERIS PHARMACEUTICALS INC
Common Stock
2019-10-11$7.97/sh−10,000→ 449,324 total
Sale
XERIS PHARMACEUTICALS INC
Common Stock
2019-07-11$12.04/sh−9,962→ 459,362 total
Sale
XERIS PHARMACEUTICALS INC
Common Stock
2019-07-11$12.70/sh−38→ 459,324 total
Sale
XERIS PHARMACEUTICALS INC
Common Stock
2019-04-11$9.56/sh−10,000→ 477,024 total
Award
XERIS PHARMACEUTICALS INC
Stock Option (right to buy)
2019-01-31+25,000→ 25,000 total
Sale
XERIS PHARMACEUTICALS INC
Common Stock
2019-01-14$17.20/sh−7,700→ 469,324 total
Sale
XERIS PHARMACEUTICALS INC
Common Stock
2019-01-11−2,300→ 487,024 total
Sale
XERIS PHARMACEUTICALS INC
Common Stock
2018-12-26$15.82/sh−15,720→ 489,324 total
Exercise/Conversion
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2018-12-24−15,720→ 0 total
Exercise/Conversion
XERIS PHARMACEUTICALS INC
Common Stock
2018-12-24$1.19/sh+15,720→ 505,044 total
Conversion
XERIS PHARMACEUTICALS INC
Common Stock
2018-06-25+30,232→ 482,193 total
Conversion
XERIS PHARMACEUTICALS INC
Series A Preferred Stock
2018-06-25−53,849→ 0 total
Conversion
XERIS PHARMACEUTICALS INC
Common Stock
2018-06-25+7,130→ 489,323 total
Conversion
XERIS PHARMACEUTICALS INC
Series B Preferred Stock
2018-06-25−12,701→ 0 total

Companies

Recent Filings

Address

C/O XERIS PHARMACEUTICALS, INC. 180 N. LASALLE STREET, SUITE 1810

CHICAGO, IL, 60601

View on SEC.gov